US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NUREXONE BIOLOGIC INC

0.4486

0.0000

Volume:- -

Turnover:- -

Market Cap:41.29M

PE:-5.21

High:0.4486

Open:0.4486

Low:0.4486

Close:0.4486

52wk High:0.8000

52wk Low:0.4086

Shares:92.05M

Float Shares:90.53M

Volume Ratio:1.85

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0860

EPS(LYR):-0.0814

ROE:-298.06%

ROA:-129.23%

PB:28.34

PE(LYR):-5.51

Loading ...

Overview Company News Filings

Company Profile

Company Name:

NUREXONE BIOLOGIC INC

Exchange:

OTCQB

Establishment Date:

2020

Employees:

- -

Office Location:

1 Adelaide Street East,Suite 801,Toronto,Ontario,Canada

Website:

http://nurexone.com

Zip Code:

M5C 2V9

Phone:

- -

Fax:

- -

Introduction:

NurExone Biologic Inc., a pharmaceutical technology company. It engages in the development of an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NRXBF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRXBF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRXBF\",,,,,undefined,":{"symbol":"NRXBF","market":"US","secType":"STK","nameCN":"NUREXONE BIOLOGIC INC","latestPrice":0.448607,"timestamp":1775160000000,"preClose":0.448607,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":90529200,"shares":92045848,"eps":-0.086028,"marketStatus":"Closed Good Friday","change":0,"latestTime":"04-02 16:00:00 EDT Delay","open":0.448607,"high":0.448607,"low":0.448607,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.086028,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.448607,"volumeRatio":1.854753501391468},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRXBF\",,,,,undefined,":{"symbol":"NRXBF","floatShares":90529200,"roa":"-129.23%","roe":"-298.06%","lyrEps":-0.081368,"volumeRatio":1.854753501391468,"shares":92045848,"dividePrice":0,"high":0.448607,"amplitude":0,"preClose":0.448607,"low":0.448607,"week52Low":0.40855,"pbRate":"28.34","week52High":0.8,"institutionHeld":0,"latestPrice":0.448607,"eps":-0.086028,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.086028,"open":0.448607,"prevYearClose":0.4889,"prevWeekClose":0.4193,"prevMonthClose":0.4299,"prevQuarterClose":0.4299,"fiveDayClose":0.4193,"twentyDayClose":0.4592,"sixtyDayClose":0.4559},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRXBF\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRXBF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRXBF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1679703579,"yearFounded":2020,"address":"1 Adelaide Street East,Suite 801,Toronto,Ontario,Canada","zipCode":"M5C 2V9","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://nurexone.com","description":"NurExone Biologic Inc., a pharmaceutical technology company. It engages in the development of an off-the-shelf, non-invasive, and novel treatment for the reversal or reduction of paralysis following spinal cord injury using membrane-bound extracellular vesicles technology, as well as to treat brain trauma injury, and other brain and neurological indications. The company was founded in 2020 and is based in Toronto, Canada.","exchange":"OTCQB","name":"NUREXONE BIOLOGIC INC","nameEN":"NUREXONE BIOLOGIC INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NRXBF\",market:\"US\",,,undefined,":null}}